Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

184.39
-1.7500-0.94%
Post-market: 184.390.00000.00%19:30 EDT
Volume:1.03M
Turnover:191.41M
Market Cap:9.66B
PE:-48.93
High:188.00
Open:186.51
Low:184.00
Close:186.14
52wk High:260.19
52wk Low:117.30
Shares:52.38M
Float Shares:43.83M
Volume Ratio:1.17
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:115.94
PE(LYR):-50.08

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Axsome adopts executive severance, change-in-control plan effective June 5, 2026

Reuters
·
Jun 10

Axsome Therapeutics shareholders elect Saad, Mahony as Class II directors

Reuters
·
Jun 10

Axsome Therapeutics CEO Herriot Tabuteau disposes of USD 11.97 million in common shares

Reuters
·
Jun 10

Axsome CFO Nick Pizzie sells 33,000 shares for $7.92 million

Reuters
·
Jun 10

What Axsome Therapeutics (AXSM)'s SUNOSI Patent Settlements and Migraine Updates Mean For Shareholders

Simply Wall St.
·
Jun 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Jun 04

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

GlobeNewswire
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

Axsome Therapeutics Reaches Settlement Over Sunosi Patent Dispute; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 03

BUZZ-Axsome Therapeutics rises after co resolves patent litigation for sleep disorder drug

Reuters
·
Jun 03

BRIEF-Axsome Therapeutics Announces Settlement Resolving All Sunosi® (Solriamfetol) Patent Litigation

Reuters
·
Jun 03

Axsome settles all Sunosi patent litigation, sets generic entry for 2040

Reuters
·
Jun 03

Axsome Therapeutics - Resolves All Patent Litigation Related to Sunosi

THOMSON REUTERS
·
Jun 03

Axsome Therapeutics - Five Companies Granted Right to Sell Generic Sunosi From 2040, Subject to FDA Approval

THOMSON REUTERS
·
Jun 03

Axsome Therapeutics - Enters Settlement Agreement With First-to-File Generic Applicant for Sunosi

THOMSON REUTERS
·
Jun 03

Axsome Therapeutics director Mark Coleman disposes of common shares worth $4.06 million

Reuters
·
Jun 03